Home/ Supplements/ Alpha Lipoic Acid/ QGel Coenzyme Q10 30 mg + Alpha Lipoic A...

QGel Coenzyme Q10 30 mg + Alpha Lipoic Acid 50 mg

product on market Softgel Capsule Tishcon Corp. Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Coenzyme Q10 and Alpha Lipoic Acid are supported by moderate evidence for their roles in cellular energy production and antioxidant defense. Vitamin E further contributes to the neutralization of free radicals. Together, these ingredients target oxidative stress, though the overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for QGel Coenzyme Q10 30 mg + Alpha Lipoic Acid 50 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softsule(s)(R)
Serving Size
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 IU (333% DV)
4.5× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
30 mg
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews

Other Ingredients

Medium Chain Triglycerides Gelatin Polysorbate 80 Glycerin Sorbitol Beeswax purified Water hydroxylated Lecithin Titanium Dioxide Annatto extract
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take one (1) softsule(R) daily as a dietary supplement or as directed by your healthcare professional. Softsule(R) to be taken with or after a meal.

Warnings & Precautions

KEEP OUT OF THE REACH OF CHILDREN.

If you are pregnant or nursing a baby, seek the advice of a health professional before using this product.

THE BOTTLE CAP ON THIS PRODUCT IS SECURED WITH AN IMPRINTED PLASTIC SEAL. DO NOT USE THIS PRODUCT IF SEAL IS CUT, TORN, BROKEN OR MISSING.

Contains soy.

Formulation Notes

Contains soy.

Free of: milk & milk by-products, egg & egg by-products, fish, shellfish, tree nuts, peanuts/oil, wheat, starch and yeast.

Additional Information

Keep bottle tightly closed. Store between 15(0)-30(0)C (59(0)-86(0)F). Do not refrigerate

MADE IN THE U.S.A.

CoQ10 Pure(R)

HYDROSOLUBLE(TM) LIPOSOLUBLE(TM)

6948seg 180cc R0113

NDC 54023-6948-2

Cellular Energizer Clinically Tested Enhanced Absorption

Metadata

Product Details

UPC / SKU0 14654 99105 8
DSLD Entry Date2015-06-25
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID46303
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.